Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
about
Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationIndependent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomasDroplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancersChanging the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma.Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.Genomic sequencing and precision medicine in head and neck cancers.Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.Targeting calcium signaling in cancer therapy.Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer.The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencingGenomic analysis of head and neck cancer cases from two high incidence regions.PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma.Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition.The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancerEffect Sizes of Somatic Mutations in CancerSextuple Tumors in Head and Neck Area: Evidence of Field Cancerization
P2860
Q26744490-07E0F83F-FD90-4DBE-9A7A-150167299B98Q28277102-F7885065-1630-45C2-AF3B-8BE2303FA2B9Q33814851-5069C20C-8366-4390-A601-5F45B6A5186DQ35925179-91815DFC-6693-4EA2-81E8-0EE58564AF75Q36849676-9DC39367-85B3-4252-AE5B-DC4BB0080AB6Q37641638-55A7C0D9-240B-4C67-AEA0-D2EA927565DAQ37644922-242117B1-2CB5-4D7A-B2E3-F59FD12A9307Q38731474-FC67EE1C-56D1-45E5-AAD2-051EE43DEE03Q38735678-041B5730-23BA-4443-95E0-6599107E6386Q38756969-4ADEEC0E-E698-467B-922D-BFB8F67F9BB3Q38776454-45DDA5F9-9E56-48BF-8155-75614FBFAD5AQ38855031-982251D5-7047-4483-9B64-DCC2714517DCQ39101957-AB832CEB-9892-4DF2-A6E7-2597612F0E9AQ39182541-CF8813F6-796F-43A8-9265-8F4B75D77E7CQ40255513-5D318AB1-C27E-4E02-9A58-09CDFF610D7FQ42183763-9D605DD5-429E-40A3-BAC2-F359E6979AB4Q48149825-F1ABF4C2-4CFA-4DFC-B734-C46B2A744D5EQ48507317-899F6AA1-2521-4DCC-8FD1-A82D577BE80BQ48949605-A8642EBD-8783-46D5-BB4D-28FF82077E6DQ50107195-AE829660-4659-4F67-AA39-5DFE327C427DQ50962433-AD65E560-5732-400E-8BD7-495A9090358CQ51418643-69967B00-5EC7-4771-8CD6-E33D41FF0C53Q52723099-E0814241-740E-4502-B57A-731A29BD7DB7Q53688963-63C51DA4-7565-41AB-A57A-B66635644056Q57174763-B1EBEBE8-9A0F-4DC8-9A18-0D7C831840EBQ58545847-0D446D6A-AC59-4062-92C2-B4F51701E69DQ58776908-369524E2-B2C8-42FE-9EB5-061CA7C7D0B6
P2860
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@ast
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@en
type
label
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@ast
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@en
prefLabel
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@ast
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
@en
P2093
P2860
P50
P356
P1476
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
@en
P2093
Gerald Goh
Julie E Bauman
Maria L Freilino
Richard P Lifton
William E Gooding
P2860
P304
P356
10.1172/JCI82066
P407
P577
2015-11-30T00:00:00Z